(NASDAQ:SVRA), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Savara Inc. (“Savara” or the “Company”) (NASDAQ: SVRA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Savara and certain of its officers and/or directors have engaged […]
GENEVA, Ill., July 01, 2025 (GLOBE NEWSWIRE) — Iteris, Inc., the world's trusted technology ecosystem for smart mobility infrastructure management and part of Almaviva Group, today announced that it has been awarded a three-year contract renewal by the Kane County Division of Transportation (Kane County DOT) to support a comprehensive smart mobility, safety and sustainability
NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — TransPerfect, the world's largest provider of language and AI solutions for global business, today announced that its TransPerfect Media division, specializing in audiovisual post-production and localization services, supported four award-winning films at the 2025 Cannes Film Festival. TransPerfect Media and its recently acquired studio MPC Paris provided
(NASDAQ:SMLR), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ: SMLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Semler and certain of its officers and/or directors have
(NASDAQ:ABL), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Abacus and certain of its officers and/or directors
(NASDAQ:HNRG), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Hallador Energy Company (“Hallador” or the “Company”) (NASDAQ: HNRG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Hallador and certain of its officers and/or directors have
(NYSE:BF-B),(NYSE:BF-A), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Brown-Forman Corporation (“Brown-Forman” or the “Company”) (NYSE: BF-B; BF-A). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Brown-Forman and certain of its officers and/or directors have
(NasdaqGM:SMMT), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Summit Therapeutics Inc. (“Summit” or the “Company”) (NASDAQ: SMMT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Summit and certain of its officers and/or directors have
(NasdaqGM:NPCE), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of NeuroPace, Inc. (“NeuroPace” or the “Company”) (NASDAQ: NPCE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether NeuroPace and certain of its officers and/or directors have engaged
(NASDAQ:PLAB), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Photronics, Inc. (“Photronics” or the “Company”) (NASDAQ: PLAB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Photronics and certain of its officers and/or directors have engaged